These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27112378)

  • 1. Next-generation sequencing in clinical practice: from the patients' preferences to the informed consent process.
    Pélissier A; Peyron C; Béjean S
    Public Health; 2016 Sep; 138():157-9. PubMed ID: 27112378
    [No Abstract]   [Full Text] [Related]  

  • 2. Next-generation sequencing applied to rare diseases genomics.
    Danielsson K; Mun LJ; Lordemann A; Mao J; Lin CH
    Expert Rev Mol Diagn; 2014 May; 14(4):469-87. PubMed ID: 24702023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation sequencing for diagnosis of rare diseases in the neonatal intensive care unit.
    Daoud H; Luco SM; Li R; Bareke E; Beaulieu C; Jarinova O; Carson N; Nikkel SM; Graham GE; Richer J; Armour C; Bulman DE; Chakraborty P; Geraghty M; Lines MA; Lacaze-Masmonteil T; Majewski J; Boycott KM; Dyment DA
    CMAJ; 2016 Aug; 188(11):E254-E260. PubMed ID: 27241786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informed consent for exome sequencing in diagnostics: exploring first experiences and views of professionals and patients.
    Rigter T; van Aart CJ; Elting MW; Waisfisz Q; Cornel MC; Henneman L
    Clin Genet; 2014 May; 85(5):417-22. PubMed ID: 24117109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next generation sequencing: considering the ethics.
    Davey S
    Int J Immunogenet; 2014 Dec; 41(6):457-62. PubMed ID: 25345691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality and extent of informed consent for invasive procedures: a pilot study at the institutional level in Turkey.
    Dogan HH; Işik E; Vural E; Vehid H; Brezis M
    Int J Qual Health Care; 2015 Feb; 27(1):46-51. PubMed ID: 25502322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing the ethical challenges of next-generation sequencing in genomic medicine.
    Clarke AJ
    Br Med Bull; 2014 Sep; 111(1):17-30. PubMed ID: 25122627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Professionals' attitudes regarding large-scale genetic information generated through next generation sequencing in research: a pilot study.
    Miller J; Soulier A; Bertier G; Cambon-Thomsen A
    J Empir Res Hum Res Ethics; 2014 Jul; 9(3):56-8. PubMed ID: 25746785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Content Analysis of Informed Consent for Whole Genome Sequencing Offered by Direct-to-Consumer Genetic Testing Companies.
    Niemiec E; Borry P; Pinxten W; Howard HC
    Hum Mutat; 2016 Dec; 37(12):1248-1256. PubMed ID: 27647801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meeting Patients' Right to the Correct Diagnosis: Ongoing International Initiatives on Undiagnosed Rare Diseases and Ethical and Social Issues.
    Gainotti S; Mascalzoni D; Bros-Facer V; Petrini C; Floridia G; Roos M; Salvatore M; Taruscio D
    Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30248891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ethics and rare diseases].
    Briard ML
    Soins; 2003; (672):37-9. PubMed ID: 12655822
    [No Abstract]   [Full Text] [Related]  

  • 12. Next generation sequencing technologies for rare Mendelian disorders: striking potential and ongoing challenges.
    Hoffjan S
    Mol Cell Probes; 2015 Oct; 29(5):259. PubMed ID: 26257290
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidental findings and the need for a revised informed consent process.
    Kole J; Fiester A
    AJR Am J Roentgenol; 2013 Nov; 201(5):1064-8. PubMed ID: 23902536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities and technical challenges in next-generation sequencing for diagnosis of rare pediatric diseases.
    Bacchelli C; Williams HJ
    Expert Rev Mol Diagn; 2016 Oct; 16(10):1073-1082. PubMed ID: 27560481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next generation sequencing in psychiatric research: what study participants need to know about research findings.
    Mathieu G; Groisman IJ; Godard B
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):2119-27. PubMed ID: 23725748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward greater understanding of patient decision-making around genome sequencing.
    Hull LE; Vassy JL
    Per Med; 2018 Jan; 15(1):57-66. PubMed ID: 29714114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of Next-Generation Sequencing in Rare Renal Diseases].
    Cai ZY; Zhao JR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):484-490. PubMed ID: 35791948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental findings during a surgical procedure-patient and public perspectives.
    van Rij AM; Thomas J; McKenzie R; Diong J; Frizelle F; Snelling J; Anderson L
    N Z Med J; 2018 Feb; 131(1469):20-31. PubMed ID: 29389925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of Commercially Available Epilepsy Genetic Panels.
    Chambers C; Jansen LA; Dhamija R
    J Genet Couns; 2016 Apr; 25(2):213-7. PubMed ID: 26536886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taking the next step forward - Diagnosing inherited infantile cholestatic disorders with next generation sequencing.
    Herbst SM; Schirmer S; Posovszky C; Jochum F; Rödl T; Schroeder JA; Barth TF; Hehr U; Melter M; Vermehren J
    Mol Cell Probes; 2015 Oct; 29(5):291-8. PubMed ID: 25771912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.